New York-based AI biotechnology company Paige has collaborated with Ohio State College Wexner Medical Center (OSWMC) and its affiliated hospitals to study the use of AI tools in determining cancer in a community hospital.
The partnership will leverage Paige’s Prostate Suite, including the only FDA-approved AI-powered pathology tool, Paige Prostate Detect, to compare the disparities between diagnoses performed with and without AI.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.